MAPT and Alzheimer disease: To examine whether tau containing exosomes derived from the cerebrospinal fluid (CSF) of AD patients are seed‐competent, tauRDΔK SLC biosensor was generated with two halves of luciferase fusing to tauRD containing ΔK280 mutation and expressed in N2a cells.28